# Consideration of baseline comorbidities in studies on HER2-positive metastatic breast cancer

**Authors:** Amir Reza Akbari, Benyamin Alam

PMC · DOI: 10.1093/oncolo/oyaf335 · The Oncologist · 2025-10-06

## Full-text entities

- **Genes:** ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}
- **Diseases:** breast cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12605735/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12605735/full.md

---
Source: https://tomesphere.com/paper/PMC12605735